Latest1 information on COVID-19

Blood Loss Measurement During Cesarean Delivery

Not Recruiting

Trial ID: NCT02667600

Age - 18 Years-50 Years Gender - Female Accepting Healthy Volunteers - No

Purpose

The aim of this study is to assess the ability of the Triton Device to measure blood loss among women undergoing elective and non-elective cesarean delivery. This patient population often experiences significant blood loss during surgery, and measurements of surgical blood loss are often inaccurate.

Official Title

Study Assessing Blood Loss Measurement During Cesarean Delivery With Triton Device

Stanford Investigator(s)

Alex Butwick
Alex Butwick

Professor of Anesthesiology, Perioperative and Pain Medicine (OB)

Eligibility


Inclusion Criteria:

   - American Society of Anesthesiologists physical status class I-III

   - undergoing Cesarean delivery under neuraxial anesthesia

   - age between 18 and 50

   - gestational age greater than or equal to 37 completed weeks

   - all ethnicities

Exclusion Criteria:

   - contraindication for epidural or spinal analgesia (bleeding diathesis, neuropathy,
   severe scoliosis, local anesthetic allergy)

   - inability to adequately understand the consent form

View More
View Less

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305

©2022 Stanford Medicine